Showing results (171-180 of 178) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 178 results.
Endocrinology|November 26, 2009
Functional effects of polymorphisms in the human gene encoding 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1): a sequence variant at the translation start of 11 beta-HSD1 alters enzyme levelsElise L V Malavasi, Val Kelly, Nikita Nath, et al.
Endocrinology|May 23, 2013
Maternal obesity has little effect on the immediate offspring but impacts on the next generationVicky King, Rachel S Dakin, Lincoln Liu, et al.
Plos Pathogens|February 7, 2015
Manipulating adenovirus hexon hypervariable loops dictates immune neutralisation and coagulation factor X-dependent cell interaction in vitro and in vivoJiangtao Ma, Margaret R Duffy, Lin Deng, et al.
Trials|January 16, 2023
Statistical analysis plan for the motor neuron disease systematic multi-arm adaptive randomised trial (MND-SMART)Richard A Parker, Christopher J Weir, Tra My Pham, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 28, 2006
Insights into the mechanisms of action of anti-Abeta antibodies in Alzheimer's disease mouse modelsYona Levites, Lisa A Smithson, Robert W Price, et al.
Journal of the American College of Cardiology|May 30, 2015
Reducing In-Stent Restenosis: Therapeutic Manipulation of miRNA in Vascular Remodeling and InflammationRobert A McDonald, Crawford A Halliday, Ashley M Miller, et al.
BMJ Open|July 7, 2022
Motor Neuron Disease Systematic Multi-Arm Adaptive Randomised Trial (MND-SMART): a multi-arm, multi-stage, adaptive, platform, phase III randomised, double-blind, placebo-controlled trial of repurposed drugs in motor neuron diseaseCharis Wong, Rachel S Dakin, Jill Williamson, et al.
The Lancet. Neurology|September 22, 2024
Safety and efficacy of memantine and trazodone versus placebo for motor neuron disease (MND SMART): stage two interim analysis from the first cycle of a phase 3, multiarm, multistage, randomised, adaptive platform trialSuvankar Pal, Jeremy Chataway, Robert Swingler, et al.
Pageof 18